Alpha Lipoic Acid Market Size & Share 2021 to 2027

Market Size by Product (R-Lipoic Acid, S- Lipoic Acid), by Application (Dietary Supplements, Medical Drugs, Slimming Products) & Forecast.

Report ID: GMI1605

Published Date: June 2021

Report Format: PDF

Download Free PDF

Alpha Lipoic Acid Market Size

Alpha Lipoic Acid market size was USD 805.7 million in 2020 and will grow at 6.3% CAGR from 2021 to 2027. Increasing penetration of alpha lipoic acid in the healthcare sector will augment the product demand.

Alpha Lipoic also known as thioctic acid is an organosulfur compound derived from caprylic acid. This acid is widely used for breaking down carbohydrates for efficient functioning of various organs.

Alpha Lipoic Acid Market Outlook

The robust dietary supplement demand, particularly in Asia Pacific, on account of improving consumer socio-economic factors along with consumer awareness toward maintaining a healthy & fit lifestyle, has been propelling the overall alpha lipoic acid market share in recent years. For instance, the product is used by youth and fitness enthusiasts in gyms and other sports centers. Furthermore, the product is also preferred as a dietary supplement owing to its biological characteristics (non-toxic).

The increasing consumer spending toward personal care products will subsequently complement the global alpha lipoic acid market by 2027. The product is widely used across cosmetic products such as anti-aging creams. Additionally, the consumption of prescribed & regular alpha lipoic acid helps in reducing body weight and is thus preferred as a slimming agent in the market.

Alpha Lipoic acid is a biologically active antioxidant, which is water & fat-soluble, making it suitable for wind applications as a medical drug and dietary supplement. However, 100% pure R-lipoic acid is not commercially available and is therefore available as a racemic mixture of R-(natural) and S-(unnatural). The increasing government initiatives coupled with government campaigns are likely to stimulate the product demand in the coming years. However, the presence of substitutes, such as B-alanine, chromium, Coenzyme Q10, creatine, energy drinks, glutamine, etc., is anticipated to be a major factor restraining the overall alpha lipoic acid market revenue during the assessment period.

Alpha Lipoic Acid Market Analysis

Alpha Lipoic Acid Market by Product

The R-lipoic acid segment is projected reach a market share of over 87% by the end of 2027. R-lipoic acid has a wide range of applications in preventing diabetes, influencing glucose control & neuro disorders, reducing weight, protecting against cataract formation, reducing brain damage after a stroke, reducing toxic metals from the body, improving skin texture, and reducing migraine intensity, which must be treated effectively to improve the health standards across the globe.

For instance, as per the WHO, the global diabetes prevalence among adults over 18 years of age was 4.7% in 1980 and reached over 9% in 2016. Henceforth, the prevailing product demand in the medical industry and food & nutrition sector will make a significant contribution to the R-lipoic acid market size in the coming years.

Alpha Lipoic Acid Market by Application

The medical drugs segment dominated the global market and accounted for 44.6% industry share in 2020. Additionally, it is forecast to attain a market share of 50% by 2027. The increasing product applications in manufacturing several drugs that can treat numerous fatal disease including diabetes, nerve pains, cataract formation, cancer treatment, blood sugar levels, skin discoloration, HIV, healing wounds, decreasing complications in Coronary Artery Bypass Graft (CABG) surgeries, and various other medical conditions will help the medical drugs application segment attain a significant alpha lipoic acid market value during the forecast period.

The other segment is projected to grow at 5.2% CAGR throughout the assessment period. The other segment includes personal care, pet care, and metal chelation. The product protects the body against toxic metal contaminants found in the environment and food supply.

Alpha Lipoic Acid Market by Region

Asia Pacific, chiefly led by China and India, accounted for 36.2% of the overall alpha lipoic acid market share in 2020. In addition, the region will experience the highest growth rate of 6.8% from 2020 to 2027. The escalating medical industry, massive population with diabetes, and improved consumer spending toward personal well-being (dietary supplements and personal care products) are some of the chief regional growth prospects. The prevalence of a large number of small, large, and medium scale product manufacturers in the region to meet high product demand is another factor for this massive industry share in Asia Pacific.

Alpha Lipoic Acid Market Share

Key players operating in the alpha lipoic acid industry are focusing on production capacity expansion. Some of the major players operating in the market include

Infa Group (Olon S.p.A.)
Suzhou Fushilai Pharmaceutical
HiMedia Laboratories
MTC Industries
Shandong Qidu Pharmaceutical
Qufu Maidesen Fine Chemical
Shanghai Shyndec (Modern) Pharmaceutical
Jiangsu Tohope Pharmaceutical
GeroNova Research
Source Naturals

The alpha lipoic acid market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2027 for the following segments:

By Product

R- Lipoic
S-Lipoic

By Application

Dietary supplements
Slimming products
Medical drugs
Others

The above information is provided on a regional and country basis for the following:

By Region

North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- Thailand
Latin America
- Brazil
- Mexico
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa

Authors: Kiran Pulidindi, Kunal Ahuja

Alpha Lipoic Acid Market Scope

Alpha Lipoic Acid Market Size
Alpha Lipoic Acid Market Trends

Alpha Lipoic Acid Market Analysis
Alpha Lipoic Acid Market Share

Report Content

Chapter 1 Methodology & Scope

1.1 Market definitions

1.2 Base estimates & working

1.2.1 North America

1.2.2 Europe

1.2.3 Asia Pacific

1.2.4 Latin America

1.2.5 Middle East & Africa

1.3 Forecast calculations

1.3.1 COVID-19 impact calculations on industry forecast

1.4 Data Sources

1.4.1 Primary

1.4.2 Secondary

Chapter 2 Executive Summary

2.1 Global alpha lipoic acid industry 360° synopsis, 2016 - 2027

2.1.1 Business trends

2.1.2 Product trends

2.1.3 Application trends

2.1.4 Region trends

Chapter 3 Alpha Lipoic Acid Industry Insights

3.1 Industry segmentation

3.2 Industry size and forecast, 2016 – 2027

3.2.1 COVID-19 impact on industry size

3.3 Industry ecosystem analysis

3.3.1 Vendor matrix

3.3.2 Distribution channel analysis

3.3.2.1 COVID-19 disruption on distribution channel

3.4 Industry impact forces

3.4.1 Growth drivers

3.4.1.1 Improving health standards in Asia Pacific

3.4.1.2 Robust product demand for medical applications in North America

3.4.2 Industry pitfalls & challenges

3.4.2.1 Limited product use due to its side effects

3.4.2.2 Availability of several product substitutes

3.5 Regulatory trends

3.5.1 U.S.

3.5.2 Europe

3.5.3 China

3.6 Growth potential analysis, 2020

3.7 Porter’s analysis

3.7.1 Supplier’s power

3.7.2 Buyer power

3.7.3 Threat of new entrant

3.7.4 Threat of substitute

3.8 Company market share analysis, 2020

3.8.1 Strategy landscape

3.9 PESTEL analysis

3.10 Regional price trends

3.11 COVID-19 impact on alpha lipoic acid demand by application

3.11.1 Dietary supplements

3.11.2 Slimming products

3.11.3 Medical drugs

3.11.4 Others

Chapter 4 Alpha Lipoic Acid Market, By Product

4.1 Alpha lipoic acid market share by product, 2020 & 2027

4.2 R-lipoic acid

4.2.1 Market estimates and forecast, 2016 - 2027

4.2.2 Market estimates and forecast, by region, 2016 - 2027

4.3 S-lipoic acid

4.3.1 Market estimates and forecast, 2016 - 2027

4.3.2 Market estimates and forecast, by region, 2016 - 2027

Chapter 5 Alpha Lipoic Acid Market, By Application

5.1 Global alpha lipoic acid market share by application, 2020 & 2027

5.2 Dietary Supplements

5.2.1 Market estimates and forecast, 2016 - 2027

5.2.2 Market estimates and forecast, by region, 2016 - 2027

5.3 Slimming Products

5.3.1 Market estimates and forecast, 2016 - 2027

5.3.2 Market estimates and forecast, by region, 2016 - 2027

5.4 Medical Drugs

5.4.1 Market estimates and forecast, 2016 - 2027

5.4.2 Market estimates and forecast, by region, 2016 - 2027

5.5 Others

5.5.1 Market estimates and forecast, 2016 - 2027

5.5.2 Market estimates and forecast, by region, 2016 - 2027

Chapter 6 Alpha Lipoic Acid Market, By Region

6.1 Alpha lipoic acid market share by region, 2020 & 2027

6.2 North America

6.2.1 Market estimates and forecast, 2016 - 2027

6.2.2 Market estimates and forecast, by product, 2016 - 2027

6.2.3 Market estimates and forecast, by application, 2016 - 2027

6.2.4 U.S.

6.2.4.1 Market estimates and forecast, 2016 - 2027

6.2.4.2 Market estimates and forecast, by product, 2016 - 2027

6.2.4.3 Market estimates and forecast, by application, 2016 - 2027

6.2.5 Canada

6.2.5.1 Market estimates and forecast, 2016 - 2027

6.2.5.2 Market estimates and forecast, by product, 2016 - 2027

6.2.5.3 Market estimates and forecast, by application, 2016 - 2027

6.3 Europe

6.3.1 Market estimates and forecast, 2016 - 2027

6.3.2 Market estimates and forecast, by product, 2016 - 2027

6.3.3 Market estimates and forecast, by application, 2016 - 2027

6.3.4 UK

6.3.4.1 Market estimates and forecast, 2016 - 2027

6.3.4.2 Market estimates and forecast, by product, 2016 - 2027

6.3.4.3 Market estimates and forecast, by application, 2016 - 2027

6.3.5 Germany

6.3.5.1 Market estimates and forecast, 2016 - 2027

6.3.5.2 Market estimates and forecast, by product, 2016 - 2027

6.3.5.3 Market estimates and forecast, by application, 2016 - 2027

6.3.6 France

6.3.6.1 Market estimates and forecast, 2016 - 2027

6.3.6.2 Market estimates and forecast, by product, 2016 - 2027

6.3.6.3 Market estimates and forecast, by application, 2016 - 2027

6.3.7 Spain

6.3.7.1 Market estimates and forecast, 2016 - 2027

6.3.7.2 Market estimates and forecast, by product, 2016 - 2027

6.3.7.3 Market estimates and forecast, by application, 2016 - 2027

6.3.8 Italy

6.3.8.1 Market estimates and forecast, 2016 - 2027

6.3.8.2 Market estimates and forecast, by product, 2016 - 2027

6.3.8.3 Market estimates and forecast, by application, 2016 - 2027

6.4 Asia Pacific

6.4.1 Market estimates and forecast, 2016 - 2027

6.4.2 Market estimates and forecast, by product, 2016 - 2027

6.4.3 Market estimates and forecast, by application, 2016 - 2027

6.4.4 China

6.4.4.1 Market estimates and forecast, 2016 - 2027

6.4.4.2 Market estimates and forecast, by product, 2016 - 2027

6.4.4.3 Market estimates and forecast, by application, 2016 - 2027

6.4.5 Japan

6.4.5.1 Market estimates and forecast, 2016 - 2027

6.4.5.2 Market estimates and forecast, by product, 2016 - 2027

6.4.5.3 Market estimates and forecast, by application, 2016 - 2027

6.4.6 India

6.4.6.1 Market estimates and forecast, 2016 - 2027

6.4.6.2 Market estimates and forecast, by product, 2016 - 2027

6.4.6.3 Market estimates and forecast, by application, 2016 - 2027

6.4.7 Australia

6.4.7.1 Market estimates and forecast, 2016 - 2027

6.4.7.2 Market estimates and forecast, by product, 2016 - 2027

6.4.7.3 Market estimates and forecast, by application, 2016 - 2027

6.4.8 Indonesia

6.4.8.1 Market estimates and forecast, 2016 - 2027

6.4.8.2 Market estimates and forecast, by product, 2016 - 2027

6.4.8.3 Market estimates and forecast, by application, 2016 - 2027

6.4.9 Thailand

6.4.9.1 Market estimates and forecast, 2016 - 2027

6.4.9.2 Market estimates and forecast, by product, 2016 - 2027

6.4.9.3 Market estimates and forecast, by application, 2016 - 2027

6.4.10 Malaysia

6.4.10.1 Market estimates and forecast, 2016 - 2027

6.4.10.2 Market estimates and forecast, by product, 2016 - 2027

6.4.10.3 Market estimates and forecast, by application, 2016 - 2027

6.5 Latin America

6.5.1 Market estimates and forecast, 2016 - 2027

6.5.2 Market estimates and forecast, by product, 2016 - 2027

6.5.3 Market estimates and forecast, by application, 2016 - 2027

6.5.4 Brazil

6.5.4.1 Market estimates and forecast, 2016 - 2027

6.5.4.2 Market estimates and forecast, by product, 2016 - 2027

6.5.4.3 Market estimates and forecast, by application, 2016 - 2027

6.5.5 Mexico

6.5.5.1 Market estimates and forecast, 2016 - 2027

6.5.5.2 Market estimates and forecast, by product, 2016 - 2027

6.5.5.3 Market estimates and forecast, by application, 2016 - 2027

6.6 Middle East & Africa

6.6.1 Market estimates and forecast, 2016 - 2027

6.6.2 Market estimates and forecast, by product, 2016 - 2027

6.6.3 Market estimates and forecast, by application, 2016 - 2027

6.6.4 Saudi Arabia

6.6.4.1 Market estimates and forecast, 2016 - 2027

6.6.4.2 Market estimates and forecast, by product, 2016 - 2027

6.6.4.3 Market estimates and forecast, by application, 2016 - 2027

6.6.5 UAE

6.6.5.1 Market estimates and forecast, 2016 - 2027

6.6.5.2 Market estimates and forecast, by product, 2016 - 2027

6.6.5.3 Market estimates and forecast, by application, 2016 - 2027

6.6.6 South Africa

6.6.6.1 Market estimates and forecast, 2016 - 2027

6.6.6.2 Market estimates and forecast, by product, 2016 - 2027

6.6.6.3 Market estimates and forecast, by application, 2016 - 2027

Chapter 7 Company Profiles

7.1 Infa Group (Olon S.p.A.)

7.1.1 Business Overview

7.1.2 Financial Data

7.1.3 Product Landscape

7.1.4 Strategic Outlook

7.1.5 SWOT Analysis

7.2 Suzhou Fushilai Pharmaceutical Co., Ltd.

7.2.1 Business Overview

7.2.2 Financial Data

7.2.3 Product Landscape

7.2.4 SWOT Analysis

7.3 MTC Industries, Inc.

7.3.1 Business Overview

7.3.2 Financial Data

7.3.3 Product Landscape

7.3.4 Strategic Outlook

7.3.5 SWOT Analysis

7.4 Qufu Maidesen Fine Chemical Co., Ltd.

7.4.1 Business Overview

7.4.2 Financial Data

7.4.3 Product Landscape

7.4.4 SWOT Analysis

7.5 Shandong Qidu Pharmaceutical Co., Ltd.

7.5.1 Business Overview

7.5.2 Financial Data

7.5.3 Product Landscape

7.5.4 SWOT Analysis

7.6 Shanghai Shyndec (Modern) Pharmaceutical Co., Ltd.

7.6.1 Business Overview

7.6.2 Financial Data

7.6.3 Product Landscape

7.6.4 Strategic Outlook

7.6.5 SWOT Analysis

7.7 Jiangsu Tohope Pharmaceutical Co., Ltd.

7.7.1 Business Overview

7.7.2 Financial Data

7.7.3 Product Landscape

7.7.4 SWOT Analysis

7.8 GeroNova Research, Inc.

7.8.1 Business Overview

7.8.2 Financial Data

7.8.3 Product Landscape

7.8.4 SWOT Analysis

7.9 Source Naturals, Inc.

7.9.1 Business Overview

7.9.2 Financial Data

7.9.3 Product Landscape

7.9.4 SWOT Analysis

7.10 HiMedia Laboratories Pvt., Ltd.

7.10.1 Business Overview

7.10.2 Financial Data

7.10.3 Product Landscape

7.10.4 Strategic Outlook

7.10.5 SWOT Analysis

7.11 AlzChem AG

7.11.1 Business Overview

7.11.2 Financial Data

7.11.3 Product Landscape

7.11.4 SWOT Analysis

7.12 Sabinsa Corporation

7.12.1 Business Overview

7.12.2 Financial Data

7.12.3 Product Landscape

7.12.4 Strategic Outlook

7.12.5 SWOT Analysis

7.13 Now Health Group, Inc.

7.13.1 Business Overview

7.13.2 Financial Data

7.13.3 Product Landscape

7.13.4 Strategic Outlook

7.13.5 SWOT Analysis

7.14 Life Extension, Inc.

7.14.1 Business Overview

7.14.2 Financial Data

7.14.3 Product Landscape

7.14.4 SWOT Analysis

7.15 Swanson Health Products, Inc.

7.15.1 Business Overview

7.15.2 Financial Data

7.15.3 Product Landscape

7.15.4 SWOT Analysis

7.16 Cambridge Commodities, Ltd.

7.16.1 Business Overview

7.16.2 Financial Data

7.16.3 Product Landscape

7.16.4 SWOT Analysis

7.17 Toyo Hakko, Co., Ltd.

7.17.1 Business Overview

7.17.2 Financial Data

7.17.3 Product Landscape

7.17.4 SWOT Analysis

Don't see your key competitors?

The companies listed in this report are a curated selection - not the full competitive universe.

Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.

Your competitive landscape may also include

Regional or domestic-only leaders not in the global top tier

Distributors and channel partners who control market access

Emerging disruptors, startups, or adjacent-industry entrants

Niche players focused on a specific application or end-use

Free customization - up to 20% of report value

Need specific data? Request customization and get the insights tailored to your exact requirements.

Authors: Kiran Pulidindi, Kunal Ahuja

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]

Explore Our Licensing Options:

Starting at: $2,450

Immediate Delivery Available

Premium Report Details

Base Year: 2020

Companies Profiled: 14

Tables & Figures: 183

Countries covered: 19

Pages: 172

Download Free PDF